StockNews.com Initiates Coverage on Concord Medical Services (NYSE:CCM)

StockNews.com initiated coverage on shares of Concord Medical Services (NYSE:CCM) in a research report issued to clients and investors on Thursday. The firm set a “sell” rating on the stock.

Concord Medical Services Price Performance

NYSE CCM opened at $5.02 on Thursday. The company has a 50-day simple moving average of $5.54 and a two-hundred day simple moving average of $6.65. Concord Medical Services has a 12-month low of $3.82 and a 12-month high of $26.70. The company has a debt-to-equity ratio of 1.15, a quick ratio of 0.46 and a current ratio of 0.47.

Concord Medical Services Company Profile

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services.